Cargando…

Applications of nanobodies in the prevention, detection, and treatment of the evolving SARS-CoV-2

Global health and economy are deeply influenced by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its newly emerging variants. Nanobodies with nanometer-scale size are promising for the detection and treatment of SARS-CoV-2 and its variants because they are superior to conventi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Wenyi, Hu, Yue, Li, Bohan, Wang, Huanan, Shen, Jinhua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9801699/ https://www.ncbi.nlm.nih.gov/pubmed/36592707 http://dx.doi.org/10.1016/j.bcp.2022.115401

Ejemplares similares

Emerging Landscape of Nanobodies and Their Neutralizing Applications against SARS-CoV-2 Virus
por: Feng, Xuemei, et al.
Publicado: (2023)

Generation and Characterization of a Nanobody Against SARS-CoV
por: Li, Jiang-Fan, et al.
Publicado: (2021)

Therapeutische Nanobodies gegen SARS-CoV-2
por: Güttler, Thomas, et al.
Publicado: (2022)

SARS-CoV-2 nanobodies 2.0
por: Labroussaa, Fabien, et al.
Publicado: (2021)

Nanobody Repertoires for Exposing Vulnerabilities of SARS-CoV-2
por: Mast, Fred D., et al.
Publicado: (2021)

Prospects of Neutralizing Nanobodies Against SARS-CoV-2
por: Chen, Fangfang, et al.
Publicado: (2021)

Nanobody-Functionalized Cellulose for Capturing SARS-CoV-2
por: Sun, Xin, et al.
Publicado: (2022)

SARS-CoV-2 detection using a nanobody-functionalized voltammetric device
por: Pagneux, Quentin, et al.
Publicado: (2022)

Structural basis of nanobodies neutralizing SARS-CoV-2 variants
por: Shi, Zhenzhong, et al.
Publicado: (2022)

Development of humanized tri-specific nanobodies with potent neutralization for SARS-CoV-2
por: Dong, Jianbo, et al.
Publicado: (2020)

Nanobody repertoire generated against the spike protein of ancestral SARS-CoV-2 remains efficacious against the rapidly evolving virus
por: Ketaren, Natalia E., et al.
Publicado: (2023)

The Development of a Novel Nanobody Therapeutic for SARS-CoV-2
por: Ye, Gang, et al.
Publicado: (2020)

Camel nanobodies broadly neutralize SARS-CoV-2 variants
por: Hong, Jessica, et al.
Publicado: (2021)

Versatile and multivalent nanobodies efficiently neutralize SARS-CoV-2
por: Xiang, Yufei, et al.
Publicado: (2020)

Two pan-SARS-CoV-2 nanobodies and their multivalent derivatives effectively prevent Omicron infections in mice
por: Liu, Honghui, et al.
Publicado: (2023)

A cell-free nanobody engineering platform rapidly generates SARS-CoV-2 neutralizing nanobodies
por: Chen, Xun, et al.
Publicado: (2021)

Applications of nanobodies in plant science and biotechnology
por: Wang, Wenyi, et al.
Publicado: (2020)

The evolving direct and indirect platforms for the detection of SARS-CoV-2
por: Fathi Karkan, Sonia, et al.
Publicado: (2022)

Isolation of an escape-resistant SARS-CoV-2 neutralizing nanobody from a novel synthetic nanobody library
por: Dormeshkin, Dmitri, et al.
Publicado: (2022)

Therapeutic applications of nanobodies against SARS-CoV-2 and other viral infections: Current update
por: Bhattacharya, Manojit, et al.
Publicado: (2023)

An alpaca nanobody neutralizes SARS-CoV-2 by blocking receptor interaction
por: Hanke, Leo, et al.
Publicado: (2020)

Versatile, Multivalent Nanobody Cocktails Efficiently Neutralize SARS-CoV-2
por: Xiang, Yufei, et al.
Publicado: (2020)

The role of single-domain antibodies (or nanobodies) in SARS-CoV-2 neutralization
por: Zebardast, Arghavan, et al.
Publicado: (2021)

Structural Biology of Nanobodies against the Spike Protein of SARS-CoV-2
por: Tang, Qilong, et al.
Publicado: (2021)

Development of potent and effective synthetic SARS-CoV-2 neutralizing nanobodies
por: Stefan, Maxwell A., et al.
Publicado: (2021)

Dromedary camel nanobodies broadly neutralize SARS-CoV-2 variants
por: Hong, Jessica, et al.
Publicado: (2022)

Preparation and characterization of nanobodies targeting SARS-CoV-2 papain-like protease
por: Qiao, Huarui, et al.
Publicado: (2023)

Author Correction: Development of humanized tri-specific nanobodies with potent neutralization for SARS-CoV-2
por: Dong, Jianbo, et al.
Publicado: (2021)

Nanobodies from camelid mice and llamas neutralize SARS-CoV-2 variants
por: Xu, Jianliang, et al.
Publicado: (2021)

Preventing SARS-CoV-2 Infection Using Anti-spike Nanobody-IFN-β Conjugated Exosomes
por: Lyu, Xiabing, et al.
Publicado: (2022)

Highly synergistic combinations of nanobodies that target SARS-CoV-2 and are resistant to escape
por: Mast, Fred D, et al.
Publicado: (2021)

Neutralization of SARS‐CoV‐2 by highly potent, hyperthermostable, and mutation‐tolerant nanobodies
por: Güttler, Thomas, et al.
Publicado: (2021)

The development of Nanosota-1 as anti-SARS-CoV-2 nanobody drug candidates
por: Ye, Gang, et al.
Publicado: (2021)

A potent alpaca-derived nanobody that neutralizes SARS-CoV-2 variants
por: Weinstein, Jules B., et al.
Publicado: (2022)

An ultrapotent synthetic nanobody neutralizes SARS-CoV-2 by stabilizing inactive Spike
por: Schoof, Michael, et al.
Publicado: (2020)

Screening, Expression, and Identification of Nanobody against SARS-CoV-2 Spike Protein
por: Su, Qianling, et al.
Publicado: (2022)

The Evolving Faces of the SARS-CoV-2 Genome
por: Schmidt, Maria, et al.
Publicado: (2021)

An ultrapotent RBD-targeted biparatopic nanobody neutralizes broad SARS-CoV-2 variants
por: Chi, Xiaojing, et al.
Publicado: (2022)

A synthetic nanobody targeting RBD protects hamsters from SARS-CoV-2 infection
por: Li, Tingting, et al.
Publicado: (2021)

Accelerating PERx reaction enables covalent nanobodies for potent neutralization of SARS-CoV-2 and variants
por: Yu, Bingchen, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_kol674g1kghf77dadl8ap31mop